<?xml version='1.0' encoding='utf-8'?>
<documents xmlns='http://eprints.org/ep2/data/2.0'>
  <document id='https://datacompass.lshtm.ac.uk/id/document/1333'>
    <docid>1333</docid>
    <rev_number>3</rev_number>
    <files>
      <file id='https://datacompass.lshtm.ac.uk/id/file/4973'>
        <fileid>4973</fileid>
        <datasetid>document</datasetid>
        <objectid>1333</objectid>
        <filename>Figure1.jpg</filename>
        <mime_type>image/jpeg</mime_type>
        <hash>2a935f6c624e70e6aa41e62ce107ac85b115e0546fe8b8164d19eec4e25ca86a</hash>
        <hash_type>SHA256</hash_type>
        <filesize>37257</filesize>
        <mtime>2016-02-17 10:51:51</mtime>
        <url>https://datacompass.lshtm.ac.uk/id/eprint/168/1/Figure1.jpg</url>
      </file>
    </files>
    <eprintid>168</eprintid>
    <pos>1</pos>
    <placement>2</placement>
    <mime_type>image/jpeg</mime_type>
    <format>Image</format>
    <language>en</language>
    <security>public</security>
    <license>cc_by</license>
    <main>Figure1.jpg</main>
    <content>data_visualisation</content>
    <retention_period>indefinite</retention_period>
    <formatdesc>ROC analysis for the prediction of detectable concentrations of HS-CTnT, in 430 CVD-free participants drawn from the Whitehall II epidemiological cohort between 2006 and 2008 in United Kingdom</formatdesc>
  </document>
</documents>
